Latest Australian Government Funding News

EMVision Medical Devices has secured a $3.8 million R&D tax rebate and gained approval to claim rebates on overseas expenditures, strengthening its financial footing as it advances clinical trials for its neurodiagnostic device.

Wide Open Agriculture has appointed Craig Swan as its new CEO, signaling a strategic push to commercialise its lupin protein technology and expand its footprint in Asia.

Regis Healthcare reported a strong 18.4% revenue increase to $667.7 million for H1 2026, despite a 44.8% drop in statutory net profit. The company expanded its aged care portfolio through key acquisitions and declared a fully franked interim dividend.

Renascor Resources is advancing its government-backed Purified Spherical Graphite demonstration facility in Adelaide, poised to challenge China’s dominance in battery anode materials with an innovative HF-free process.

Atomo Diagnostics reported a robust 121% quarter-on-quarter revenue increase to $1.5 million, driven by new orders for its FebriDx Pascal and HIV Self-Test products. The company also secured a global licensing deal for a novel liver function test and expanded manufacturing capacity to support growing demand.

Power Minerals has partnered with Australian tech firm Gega Elements to develop a gallium extraction process from its Santa Anna Project in Brazil, aiming to establish a vertically integrated supply chain amid rising global demand and supply risks.

Lindian Resources has approved the Final Investment Decision for its Kangankunde Rare Earths Project, securing full funding and a strategic partnership with Iluka Resources. The company is raising A$91.5 million via institutional placement to advance development and expansion plans.

Argenica Therapeutics has dosed the final patient in its Phase 2 trial for ARG-007 in acute ischaemic stroke, with topline results expected in Q3 2025. Meanwhile, the FDA has placed a clinical hold on its US trial application, introducing uncertainty for US development.

Sumitomo Corporation's subsidiary has gained crucial Foreign Investment Review Board approval to invest in Tivan Limited's Speewah Fluorite Project, paving the way for a significant joint venture.

Biome Australia has partnered with the Food and Beverage Accelerator (FaBA) to jointly develop its promising BMB18 probiotic strain, leveraging $50 million in Australian government funding while retaining full IP ownership.